News

21shares Unveils Innovative ETPs for DeFi Market Growth

21shares Unveils Innovative ETPs for DeFi Market Growth

21shares Expands ETP Offerings with New Product Launches

21shares has recently expanded its portfolio by introducing two exciting ETPs tailored for investors looking to tap into cutting-edge decentralized finance (DeFi) solutions. The newly launched 21shares Ethena ETP (Ticker: EENA) and 21shares Morpho ETP (Ticker: MORPH) are now available on prominent European exchanges.

The 21shares Ethena ETP (EENA)

Ethena stands out as a key player, backing USDe, a rapidly emerging digital dollar. Its structure focuses on maintaining a stable $1 value through delta-neutral hedging strategies in the crypto market. In a remarkable feat, USDe has achieved nearly $8 billion in assets under management (AUM) in a very short time, showcasing Ethena's vital role in shaping future crypto money markets.

The EENA ETP gives investors direct access to ENA, the core token of the Ethena protocol. This token is crucial for establishing the protocol's risk parameters, securing collateral frameworks, and facilitating new fee-sharing systems as USDe continues its upward trajectory.

  • Name: 21shares Ethena ETP
  • Ticker: EENA
  • ISIN: CH1506167035
  • Exchange: SIX Swiss Exchange
  • Fee: 2.5%
  • Currency: USD, EUR

Introducing the 21shares Morpho ETP (MORPH)

Morpho represents the next wave of innovation in lending platforms. Its architecture is specifically designed to empower institutions and developers to construct individualized, risk-managed lending markets. Morpho has already facilitated over $9 billion in deposits and $4 billion in active loans, servicing high-profile clients like Coinbase and Crypto.com.

The MORPH ETP offers a straightforward way for investors to gain exposure to Morpho's native token. This allows participants to engage in the evolving decentralized credit market without the complexities of direct on-chain transactions.

  • Name: 21shares Morpho ETP
  • Ticker: MORPH
  • ISIN: CH1506167027
  • Exchanges: Euronext Amsterdam, Euronext Paris
  • Fee: 2.5%
  • Currency: USD, EUR

The Vision Behind the Launches

Mandy Chiu, Global Head of Product Development at 21shares, expressed enthusiasm about these new offerings. "Our latest launches reaffirm our dedication to providing institutional-grade access to emerging areas of digital finance. Ethena and Morpho embody significant strides in decentralized financial infrastructure—one focused on the dollar and the other revolutionizing lending. Our ETPs present a transparent way for investors to capitalize on this growth using the exchanges they are already familiar with," she remarked.

This introduction of EENA and MORPH signifies yet another significant milestone for 21shares, which now boasts over 55 listed ETPs across Europe. The company has recently expanded its capabilities following its acquisition by FalconX, a major player in the digital asset brokerage space.

About 21shares

21shares has established itself as a leader in cryptocurrency exchange-traded products, offering the industry's most extensive suite of physically-backed crypto ETPs. The company aims to demystify cryptocurrency investing and create pathways between traditional finance and decentralized models. Since launching the first physically-backed crypto ETP in 2018, 21shares has garnered a robust track record in the crypto fund development space.

With a dedicated research team and specialized technology, 21shares is committed to providing investors with innovative and cost-efficient investment solutions. As a proud subsidiary of FalconX, it continues to push the envelopes within the crypto investment sphere.

Contact: audrey.belloff@21shares.com

Frequently Asked Questions

What are the new ETPs launched by 21shares?

21shares has introduced the Ethena ETP (EENA) and the Morpho ETP (MORPH) to offer exposure to innovative decentralized finance solutions.

How does the Ethena ETP work?

The Ethena ETP is linked to ENA, the token of the Ethena protocol, which supports a USD-pegged digital dollar called USDe, employing innovative hedging techniques.

What unique features does the Morpho ETP offer?

Morpho ETP gives investors direct access to the platform's native token, facilitating participation in decentralized credit markets while avoiding complex on-chain processes.

What is the fee structure for the new ETPs?

Both the Ethena ETP and Morpho ETP have a management fee of 2.5%.

How has 21shares expanded its ETP offerings?

With EENA and MORPH, 21shares now exceeds 55 listed ETPs in Europe, reflecting its commitment to expanding access to digital finance.

About The Author

About Investors Hangout

Investors Hangout is a leading online stock forum for financial discussion and learning, offering a wide range of free tools and resources. It draws in traders of all levels, who exchange market knowledge, investigate trading tactics, and keep an eye on industry developments in real time. Featuring financial articles, stock message boards, quotes, charts, company profiles, and live news updates. Through cooperative learning and a wealth of informational resources, it helps users from novices creating their first portfolios to experts honing their techniques. Join Investors Hangout today: https://investorshangout.com/

The content of this article is based on factual, publicly available information and does not represent legal, financial, or investment advice. Investors Hangout does not offer financial advice, and the author is not a licensed financial advisor. Consult a qualified advisor before making any financial or investment decisions based on this article. This article should not be considered advice to purchase, sell, or hold any securities or other investments. If any of the material provided here is inaccurate, please contact us for corrections.

Top 10 Most Recent News Articles

Stavian Group Eyes AI-Driven Southeast Asia Growth

Updated Category News Views 35

AI and Infrastructure: A New Chapter for Southeast Asia What does Southeast Asia's future look like with AI steering the ship? Well, there's a fresh breeze of change blowing, and right at the heart of it stands Stavian Group. At the recently held inaugural Fortune SEA500 Summit in Ho Chi Minh City, this conglomerate threw its hat into the ring, painting a vision of growth...

Continue Reading
Antengene’s AnTenGager-D2 Advances in Cancer Treatment

Updated Category News Views 51

Antengene's AnTenGager-D2 Offers Fresh Hope Alright, let's dig into the latest buzz from the 2026 Society for Immunotherapy of Cancer conference about Antengene's AnTenGager-D2 platform. If you're not into biotech lingo, buckle up, because this is a ride into the future of cancer treatments—where science fiction might soon become science fact. A Novel Approach to Tumor...

Continue Reading
Innovent's SINTBILO® Hits Primary Endpoint in Study

Updated Category News Views 119

Innovent's Latest Breakthrough with SINTBILO® One moment you're sipping coffee, the next you're staring at a clinical milestone. Innovent Biologics has shouted from the rooftops that their drug, SINTBILO® (tafolecimab injection), has wrapped up its Phase 3 CREDIT-5 study, snagging the primary endpoint with both hands. This isn't just any drug; it's marked as the first...

Continue Reading
ASTS Faces Class Action; Investors Beware of Pitfalls

Updated Category News Views 291

Securities Fraud Allegations Hit AST SpaceMobile Days like this remind me why we keep our eyes peeled in the stock game—AST SpaceMobile (NASDAQ: ASTS) is tangled in a web of legal drama, and it's something you can't brush off with a shrug. Class action lawsuits for securities fraud? That's like finding out the foundation's shaky beneath a skyscraper. If you've got skin...

Continue Reading
Gildan's Crisis: Investors Face Losses Amid Lawsuit

Updated Category News Views 245

Gildan Investors, Brace Yourself Poor old Gildan Activewear finds itself in hot water again, with a class action lawsuit cropping up like an unexpected storm on farmers' day. Any traders remotely involved with NYSE:GIL should pay damn close attention, because with a December 14, 2026 deadline looming, it's crunch time. The Root of the Lawsuit The plot thickens here,...

Continue Reading
Intelligent Communication Forum Eyes Global Ecosystem Shift

Updated Category News Views 595

China's Grand Vision for Intelligent Communication You know what they say about big ideas—they start in the most bustling of places. And here we are in Wuxi, a city's pulse pounding with ambition, hosting the 2026 China International Intelligent Communication Forum. Picture it: From November 8th to 10th, movers, shakers, and visionaries are scribbling new blueprints for...

Continue Reading
Cleaner Air in Bedroom May Stabilize Blood Sugar Levels

Updated Category News Views 321

Imagine a world where simply sleeping in cleaner air could affect your blood sugar. Seems far-fetched, I know. But that's where we're at with this new study out of NYU Langone Health. They're talking about using plain ol' portable air filters to help steady blood sugar levels for folks dealing with prediabetes. Turns out a cleaner bedroom might just hold the key to taming...

Continue Reading
Novo's Semaglutide Shows Promise in MASH Study

Updated Category News Views 337

Semaglutide, a name on the lips of many investors looking for breakthroughs, is making waves again. This time, the stir comes from recent findings in the MASH field, and it's got folks in white coats quite excited. Revolutionary Results from Novo Novo Nordisk has announced promising results from their phase 3 ESSENCE trial that looks into semaglutide's effects on a...

Continue Reading
Cultural Tech Fusion: The Asia-Pacific Way Forward

Updated Category News Views 0

A High-Tech Twist on Traditional Culture You ever walk into a room and see a robot perform kung fu? I'll admit, it caught me off guard at first. But that's exactly what happened at the "Enduring Heritage, Harmonious Asia-Pacific" special exhibition in Shenzhen. With all the usual high-ranking execs and cultural bigwigs there, nobody expected a showcase where Wing Chun...

Continue Reading
JNJ's Dual-Antigen Therapy Shows Promise in Prostate Cancer

Updated Category News Views 273

Exploring a New Front in Cancer Treatment Johnson & Johnson (NYSE: JNJ) just dropped a bombshell at the Society for Immunotherapy of Cancer (SITC) 2026 Annual Meeting, unveiling data that could reshape prostate cancer care. Their pioneering combo of pasritamig and JNJ-9401, a dual-antigen-targeted therapy, has the scientific community buzzing. Yeah, it's just Phase 1 baby...

Continue Reading

Top 5 Most Recently Viewed Articles

Market Reactions: Middle East Tensions and the Vance-Walz Debate

Updated Category News Views 71

Market Reactions to Middle East Tensions US stock futures are experiencing a downward trend as investors react to the escalating violence in the Middle East. With Iran claiming to have ceased its air bombardments on Israel, uncertainty still looms, as Israeli officials pledge a counterattack. This ongoing conflict has already impacted Wall Street, where equity values...

Continue Reading
Class Action Alert for Visa Inc. Shareholders Facing Losses

Updated Category News Views 91

Class Action Notification for Visa Inc. Shareholders The Gross Law Firm is reaching out to shareholders of Visa Inc. (NYSE: V) regarding an important class action that may affect them. If you purchased shares during a specific class period and have suffered losses, your participation could be significant in holding the company accountable. Understanding the Class Period...

Continue Reading
Coca-Cola's Earnings Report: Anticipated Insights and Analysis

Updated Category News Views 205

Coca-Cola's Earnings Report Overview The Coca-Cola Company (NYSE: KO) is on the cusp of unveiling its second-quarter financial results. Investors, analysts, and fans alike are closely watching what insights the beverage giant will provide during this crucial report. With notable figures in the U.S. market keeping an eye on Coca-Cola, the anticipation is palpable. Earnings...

Continue Reading
Maggiano's Unveils Gourmet Italian-American Classics Menu

Updated Category News Views 410

Introduction of Italian-American Classics at Maggiano's Maggiano's Little Italy is embracing the culinary heritage of Italian-American cuisine by introducing a new menu that reflects a dedication to high-quality ingredients and gourmet recipes. Under the expert guidance of award-winning Chef Anthony Amoroso, the restaurant's latest offerings promise to impress food...

Continue Reading
Recognizing Excellence: Pierce & O'Neill Founders Honored

Updated Category News Views 362

Pierce & O’Neill Founders Honored Among Top Attorneys Pierce & O’Neill, LLP, a renowned litigation boutique, is celebrating its founders, Jesse Pierce and Jack O’Neill, for their remarkable achievements in the legal field. Recently recognized in Lawdragon’s prestigious list of the 500 Leading Lawyers in America for 2025, this accolade showcases their exceptional...

Continue Reading